Journal articles on the topic 'Tau pet'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Tau pet.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Herholz, Karl. "Tau PET and tauopathies." European Journal of Nuclear Medicine and Molecular Imaging 43, no. 9 (May 10, 2016): 1684–85. http://dx.doi.org/10.1007/s00259-016-3406-5.
Full textZimmer, Eduardo Rigon, Antoine Leuzy, Serge Gauthier, and Pedro Rosa-Neto. "Developments in Tau PET Imaging." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 41, no. 5 (September 2014): 547–53. http://dx.doi.org/10.1017/cjn.2014.15.
Full textMattsson-Carlgren, Niklas, Emelie Andersson, Shorena Janelidze, Rik Ossenkoppele, Philip Insel, Olof Strandberg, Henrik Zetterberg, et al. "Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease." Science Advances 6, no. 16 (April 2020): eaaz2387. http://dx.doi.org/10.1126/sciadv.aaz2387.
Full textOkamura, Nobuyuki, and Kazuhiko Yanai. "Applications of tau PET imaging." Nature Reviews Neurology 13, no. 4 (March 17, 2017): 197–98. http://dx.doi.org/10.1038/nrneurol.2017.38.
Full textHiguchi, Makoto. "PET imaging of tau lesions." Folia Pharmacologica Japonica 145, no. 5 (2015): 268. http://dx.doi.org/10.1254/fpj.145.268.
Full textLowe, Val J., Tyler J. Bruinsma, Heather J. Wiste, Hoon-Ki Min, Stephen D. Weigand, Ping Fang, Matthew L. Senjem, et al. "Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults." Neurology 93, no. 1 (May 30, 2019): e29-e39. http://dx.doi.org/10.1212/wnl.0000000000007728.
Full textTan, Meng-Shan, Yu-Xiang Yang, Hui-Fu Wang, Wei Xu, Chen-Chen Tan, Chuan-Tao Zuo, Qiang Dong, Lan Tan, and Jin-Tai Yu. "PET Amyloid and Tau Status Are Differently Affected by Patient Features." Journal of Alzheimer's Disease 78, no. 3 (November 24, 2020): 1129–36. http://dx.doi.org/10.3233/jad-200124.
Full textIshikawa, A., M. Tokunaga, I. Matsumoto, T. Minamihisamatsu, S. Uchida, J. Maeda, B. Ji, et al. "Utilities of tau-pet and TSPO-pet for diagnosing severity of tau-induced disease progression." Journal of the Neurological Sciences 381 (October 2017): 664. http://dx.doi.org/10.1016/j.jns.2017.08.1869.
Full textZhang, Rui-Qi, Shi-Dong Chen, Xue-Ning Shen, Yu-Xiang Yang, Jia-Ying Lu, Mei Cui, Chuan-Tao Zuo, Qiang Dong, Lan Tan, and Jin-Tai Yu. "Elevated Tau PET Signal Depends on Abnormal Amyloid Levels and Correlates with Cognitive Impairment in Elderly Persons without Dementia." Journal of Alzheimer's Disease 78, no. 1 (October 27, 2020): 395–404. http://dx.doi.org/10.3233/jad-200526.
Full textJack, Clifford R., Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Val J. Lowe, David S. Knopman, Hugo Botha, et al. "Predicting future rates of tau accumulation on PET." Brain 143, no. 10 (June 24, 2020): 3136–50. http://dx.doi.org/10.1093/brain/awaa248.
Full textReimand, Juhan, Lyduine Collij, Philip Scheltens, Femke Bouwman, and Rik Ossenkoppele. "Association of amyloid-β CSF/PET discordance and tau load 5 years later." Neurology 95, no. 19 (September 10, 2020): e2648-e2657. http://dx.doi.org/10.1212/wnl.0000000000010739.
Full textSingleton, Ellen, Oskar Hansson, Yolande A. L. Pijnenburg, Renaud La Joie, William G. Mantyh, Pontus Tideman, Erik Stomrud, et al. "Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer’s disease." Journal of Neurology, Neurosurgery & Psychiatry 92, no. 8 (April 13, 2021): 872–80. http://dx.doi.org/10.1136/jnnp-2020-325497.
Full textJohnson, Keith. "Tau PET in aging and AD." Neurobiology of Aging 39 (March 2016): S19. http://dx.doi.org/10.1016/j.neurobiolaging.2016.01.088.
Full textShinotoh, Hitoshi, Hitoshi Shimada, Yasumasa Kokubo, Kenji Tagai, Fumitoshi Niwa, Soichiro Kitamura, Hironobu Endo, et al. "Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula." Neurology 92, no. 2 (December 7, 2018): e136-e147. http://dx.doi.org/10.1212/wnl.0000000000006736.
Full textLa Joie, Renaud, Alexandre Bejanin, Anne M. Fagan, Nagehan Ayakta, Suzanne L. Baker, Viktoriya Bourakova, Adam L. Boxer, et al. "Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample." Neurology 90, no. 4 (December 27, 2017): e282-e290. http://dx.doi.org/10.1212/wnl.0000000000004860.
Full textNeitzel, Julia, Nicolai Franzmeier, Anna Rubinski, and Michael Ewers. "Left frontal connectivity attenuates the adverse effect of entorhinal tau pathology on memory." Neurology 93, no. 4 (June 24, 2019): e347-e357. http://dx.doi.org/10.1212/wnl.0000000000007822.
Full textLa Joie, Renaud, Adrienne V. Visani, Suzanne L. Baker, Jesse A. Brown, Viktoriya Bourakova, Jungho Cha, Kiran Chaudhary, et al. "Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET." Science Translational Medicine 12, no. 524 (January 1, 2020): eaau5732. http://dx.doi.org/10.1126/scitranslmed.aau5732.
Full textBeyer, Leonie, Alexander Nitschmann, Henryk Barthel, Thilo van Eimeren, Marcus Unterrainer, Julia Sauerbeck, Ken Marek, et al. "Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury." European Journal of Nuclear Medicine and Molecular Imaging 47, no. 12 (April 21, 2020): 2911–22. http://dx.doi.org/10.1007/s00259-020-04788-w.
Full textDoecke, James D., Qiao-Xin Li, Christopher Fowler, Steven Collins, Vincent Dore, Christopher C. Rowe, Colin L. Masters, Olivier Salvado, and Victor LL Villemagne. "CSF P-TAU IS CORRELATED WITH TAU PET, WHILE Aβ PET CORRELATES WITH Aβ1-42 AND THE T-TAU/Aβ1-42 RATIO." Alzheimer's & Dementia 13, no. 7 (July 2017): P202—P203. http://dx.doi.org/10.1016/j.jalz.2017.07.067.
Full textMishra, Sushil K., Yoshiki Yamaguchi, Makoto Higuchi, and Naruhiko Sahara. "Pick’s Tau Fibril Shows Multiple Distinct PET Probe Binding Sites: Insights from Computational Modelling." International Journal of Molecular Sciences 22, no. 1 (December 31, 2020): 349. http://dx.doi.org/10.3390/ijms22010349.
Full textFranzmeier, Nicolai, Anna Rubinski, Julia Neitzel, Yeshin Kim, Alexander Damm, Duk L. Na, Hee Jin Kim, et al. "Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease." Brain 142, no. 4 (February 15, 2019): 1093–107. http://dx.doi.org/10.1093/brain/awz026.
Full textWolters, Emma E., Rik Ossenkoppele, Sander C. J. Verfaillie, Emma M. Coomans, Tessa Timmers, Denise Visser, Hayel Tuncel, et al. "Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease." European Journal of Nuclear Medicine and Molecular Imaging 47, no. 12 (April 14, 2020): 2866–78. http://dx.doi.org/10.1007/s00259-020-04758-2.
Full textSchoemaker, Dorothee, Andreas Charidimou, Maria Clara Zanon Zotin, Nicolas Raposo, Keith A. Johnson, Justin S. Sanchez, Steven M. Greenberg, and Anand Viswanathan. "Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy." Neurology 96, no. 15 (February 24, 2021): e1975-e1986. http://dx.doi.org/10.1212/wnl.0000000000011745.
Full textJack, Clifford R., Heather J. Wiste, Hugo Botha, Stephen D. Weigand, Terry M. Therneau, David S. Knopman, Jonathan Graff-Radford, et al. "The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes." Brain 142, no. 10 (September 9, 2019): 3230–42. http://dx.doi.org/10.1093/brain/awz268.
Full textJones, David T., David S. Knopman, Jonathan Graff-Radford, Jeremy A. Syrjanen, Matthew L. Senjem, Christopher G. Schwarz, Christina Dheel, et al. "In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms." Neurology 90, no. 11 (February 9, 2018): e947-e954. http://dx.doi.org/10.1212/wnl.0000000000005117.
Full textBarrio, Jorge R. "The Irony of PET Tau Probe Specificity." Journal of Nuclear Medicine 59, no. 1 (November 9, 2017): 115–16. http://dx.doi.org/10.2967/jnumed.117.198960.
Full textVillemagne, Victor L., S. Furumoto, M. T. Fodero-Tavoletti, R. S. Mulligan, G. Jones, O. Piguet, J. Hodges, et al. "81 In vivo tau imaging with PET." Neurobiology of Aging 33 (May 2012): S35. http://dx.doi.org/10.1016/j.neurobiolaging.2012.01.099.
Full textDay, Gregory S., Brian A. Gordon, Austin McCullough, Robert C. Bucelli, Richard J. Perrin, Tammie L. S. Benzinger, and Beau M. Ances. "Flortaucipir (tau) PET in LGI1 antibody encephalitis." Annals of Clinical and Translational Neurology 8, no. 2 (January 7, 2021): 491–97. http://dx.doi.org/10.1002/acn3.51297.
Full textJones, David T., Ryan A. Townley, Jonathan Graff-Radford, Hugo Botha, David S. Knopman, Ronald C. Petersen, Clifford R. Jack, Val J. Lowe, and Bradley F. Boeve. "Amyloid- and tau-PET imaging in a familial prion kindred." Neurology Genetics 4, no. 6 (December 2018): e290. http://dx.doi.org/10.1212/nxg.0000000000000290.
Full textAschenbrenner, Andrew J., Brian A. Gordon, Tammie L. S. Benzinger, John C. Morris, and Jason J. Hassenstab. "Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease." Neurology 91, no. 9 (August 1, 2018): e859-e866. http://dx.doi.org/10.1212/wnl.0000000000006075.
Full textTherriault, Joseph, Tharick A. Pascoal, Melissa Savard, Andrea L. Benedet, Mira Chamoun, Cecile Tissot, Firoza Lussier, et al. "Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease." Neurology 96, no. 1 (October 22, 2020): e81-e92. http://dx.doi.org/10.1212/wnl.0000000000011081.
Full textArenaza-Urquijo, Eider M., Scott A. Przybelski, Mary M. Machulda, David S. Knopman, Val J. Lowe, Michelle M. Mielke, Ashritha L. Reddy, et al. "Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults." Neurology 94, no. 15 (January 21, 2020): e1571-e1579. http://dx.doi.org/10.1212/wnl.0000000000008979.
Full textMattsson-Carlgren, Niklas, Antoine Leuzy, Shorena Janelidze, Sebastian Palmqvist, Erik Stomrud, Olof Strandberg, Ruben Smith, and Oskar Hansson. "The implications of different approaches to define AT(N) in Alzheimer disease." Neurology 94, no. 21 (May 12, 2020): e2233-e2244. http://dx.doi.org/10.1212/wnl.0000000000009485.
Full textSpotorno, Nicola, Julio Acosta-Cabronero, Erik Stomrud, Björn Lampinen, Olof T. Strandberg, Danielle van Westen, and Oskar Hansson. "Relationship between cortical iron and tau aggregation in Alzheimer’s disease." Brain 143, no. 5 (April 24, 2020): 1341–49. http://dx.doi.org/10.1093/brain/awaa089.
Full textMattsson, Niklas, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Michael Schöll, Philip S. Insel, Douglas Hägerström, et al. "Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease." Neurology 90, no. 5 (January 10, 2018): e388-e395. http://dx.doi.org/10.1212/wnl.0000000000004887.
Full textSmith, Ruben, Andreas Puschmann, Michael Schöll, Tomas Ohlsson, John van Swieten, Michael Honer, Elisabet Englund, and Oskar Hansson. "18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers." Brain 139, no. 9 (June 29, 2016): 2372–79. http://dx.doi.org/10.1093/brain/aww163.
Full textJie, Caitlin, Valerie Treyer, Roger Schibli, and Linjing Mu. "Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease." Pharmaceuticals 14, no. 2 (January 30, 2021): 110. http://dx.doi.org/10.3390/ph14020110.
Full textBoerwinkle, Anna H., Julie K. Wisch, Charles D. Chen, Brian A. Gordon, Omar H. Butt, Suzanne E. Schindler, Courtney Sutphen, et al. "Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease." Neurology 97, no. 1 (April 30, 2021): e76-e87. http://dx.doi.org/10.1212/wnl.0000000000012123.
Full textFranzmeier, Nicolai, Anna Dewenter, Lukas Frontzkowski, Martin Dichgans, Anna Rubinski, Julia Neitzel, Ruben Smith, et al. "Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease." Science Advances 6, no. 48 (November 2020): eabd1327. http://dx.doi.org/10.1126/sciadv.abd1327.
Full textSoleimani-Meigooni, David N., Leonardo Iaccarino, Renaud La Joie, Suzanne Baker, Viktoriya Bourakova, Adam L. Boxer, Lauren Edwards, et al. "18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases." Brain 143, no. 11 (November 2020): 3477–94. http://dx.doi.org/10.1093/brain/awaa276.
Full textSugiyama, Atsuhiko, and Hitoshi Shimada. "Tau PET Imaging for Dementia in Clinical Practice." RADIOISOTOPES 65, no. 12 (2016): 517–22. http://dx.doi.org/10.3769/radioisotopes.65.517.
Full textJack, Clifford R., Heather J. Wiste, Christopher G. Schwarz, Val J. Lowe, Matthew L. Senjem, Prashanthi Vemuri, Stephen D. Weigand, et al. "Longitudinal tau PET in ageing and Alzheimer’s disease." Brain 141, no. 5 (March 12, 2018): 1517–28. http://dx.doi.org/10.1093/brain/awy059.
Full textJohnson, Keith A., Aaron P. Schultz, Rema Raman, Michael C. Donohue, Chung-Kai Sun, Heidi IL Jacobs, Kenneth Marek, et al. "P4-321: TAU PET IN A4: PRELIMINARY REPORT." Alzheimer's & Dementia 14, no. 7S_Part_30 (July 1, 2006): P1583—P1584. http://dx.doi.org/10.1016/j.jalz.2018.07.144.
Full textZhou, Yongxia, and Bing Bai. "AV-1451 PET-TAU IMAGING QUANTIFICATION AND CORRELATIONS." Alzheimer's & Dementia 13, no. 7 (July 2017): P151. http://dx.doi.org/10.1016/j.jalz.2017.06.2584.
Full textHanyu, H., S. Shimizu, H. Sakurai, and K. Ishii. "AMYLOID AND TAU PET IN DIABETES-RELATED DEMENTIA." Innovation in Aging 1, suppl_1 (June 30, 2017): 596. http://dx.doi.org/10.1093/geroni/igx004.2087.
Full textGolla, Sandeep S. V., Tessa Timmers, Rik Ossenkoppele, Colin Groot, Sander Verfaillie, Philip Scheltens, Wiesje M. van der Flier, et al. "Quantification of Tau Load Using [18F]AV1451 PET." Molecular Imaging and Biology 19, no. 6 (April 3, 2017): 963–71. http://dx.doi.org/10.1007/s11307-017-1080-z.
Full textWatanabe, Hiroyuki, Masahiro Ono, and Hideo Saji. "Novel PET/SPECT Probes for Imaging of Tau in Alzheimer’s Disease." Scientific World Journal 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/124192.
Full textGraff-Radford, Jonathan, Eider M. Arenaza-Urquijo, David S. Knopman, Christopher G. Schwarz, Robert D. Brown, Alejandro A. Rabinstein, Jeffrey L. Gunter, et al. "White matter hyperintensities: relationship to amyloid and tau burden." Brain 142, no. 8 (June 14, 2019): 2483–91. http://dx.doi.org/10.1093/brain/awz162.
Full textBlennow, Kaj, Chun Chen, Claudia Cicognola, Kristin R. Wildsmith, Paul T. Manser, Sandra M. Sanabria Bohorquez, Zhentao Zhang, et al. "Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology." Brain 143, no. 2 (December 13, 2019): 650–60. http://dx.doi.org/10.1093/brain/awz346.
Full textMcSweeney, Melissa, Alexa Pichet Binette, Pierre-François Meyer, Julie Gonneaud, Christophe Bedetti, Hazal Ozlen, Anne Labonté, et al. "Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults." Neurology 94, no. 11 (February 3, 2020): e1190-e1200. http://dx.doi.org/10.1212/wnl.0000000000008905.
Full text